GILD - Got approved for Hepatitis B drugs as well as to use them on AIDS patients. The company has a very good income and lots of money to pour into research. They will continue to come out with products and should be a very good long term company. They have gone down from their 52 week high of 57.63 and are at 54.31 right now. They will probably go back up and test the 52 week high with the new news that has come out. Look to their earnings coming out over the next year - I bet they increase a fair amount.
$54.21 (08/22/08)
